Statin and aspirin as adjuvant therapy in hospitalised patients with SARS-CoV-2 infection: a randomised clinical trial (RESIST trial)

BACKGROUND: Statins and aspirin have been proposed for treatment of COVID-19 because of their anti-inflammatory and anti-thrombotic properties. Several observational studies have shown favourable results. There is a need for a randomised controlled trial. METHODS: In this single-center, open-label,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghati, Nirmal, Bhatnagar, Sushma, Mahendran, Manjit, Thakur, Abhishek, Prasad, Kshitij, Kumar, Devesh, Dwivedi, Tanima, Mani, Kalaivani, Tiwari, Pawan, Gupta, Ritu, Mohan, Anant, Saxena, Anita, Guleria, Randeep, Deepti, Siddharthan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270743/
https://www.ncbi.nlm.nih.gov/pubmed/35810307
http://dx.doi.org/10.1186/s12879-022-07570-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270743/
https://www.ncbi.nlm.nih.gov/pubmed/35810307
http://dx.doi.org/10.1186/s12879-022-07570-5

Ejemplares similares